Literature DB >> 28932595

When to resect following neoadjuvant therapy for esophageal cancer-issues and limitations in addressing this decision.

Emmanuel Gabriel1, Steven N Hochwald2.   

Abstract

Entities:  

Year:  2017        PMID： 28932595      PMCID： PMC5594145          DOI： 10.21037/jtd.2017.07.71

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.

Authors:  G Lin; S-Y Han; Y-P Xu; W-M Mao
Journal:  Dis Esophagus       Date:  2015-11-06       Impact factor: 3.429

2.  Novel Calculator to Estimate Overall Survival Benefit from Neoadjuvant Chemoradiation in Patients with Esophageal Adenocarcinoma.

Authors:  Emmanuel Gabriel; Kristopher Attwood; Rupen Shah; Steven Nurkin; Steven Hochwald; Moshim Kukar
Journal:  J Am Coll Surg       Date:  2017-01-29       Impact factor: 6.113

3.  Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?

Authors:  Anna Lee; Andrew T Wong; David Schwartz; Joseph P Weiner; Virginia W Osborn; David Schreiber
Journal:  Ann Thorac Surg       Date:  2016-05-04       Impact factor: 4.330

4.  Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?

Authors:  David N Ranney; Michael S Mulvihill; Babatunde A Yerokun; Zachary Fitch; Zhifei Sun; Chi-Fu Yang; Thomas A D'Amico; Matthew G Hartwig
Journal:  Eur J Cardiothorac Surg       Date:  2017-09-01       Impact factor: 4.191

5.  No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base.

Authors:  Eisar Al-Sukhni; Emmanuel Gabriel; Kristopher Attwood; Moshim Kukar; Steven J Nurkin; Steven N Hochwald
Journal:  J Am Coll Surg       Date:  2016-09-15       Impact factor: 6.113

6.  Does the timing of esophagectomy after chemoradiation affect outcome?

Authors:  Jae Y Kim; Arlene M Correa; Ara A Vaporciyan; Jack A Roth; Reza J Mehran; Garrett L Walsh; David C Rice; Jaffer A Ajani; Dipen M Maru; Manoop S Bhutani; James Welsh; Edith M Marom; Stephen G Swisher; Wayne L Hofstetter
Journal:  Ann Thorac Surg       Date:  2011-10-01       Impact factor: 4.330

7.  Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Authors:  Talha Shaikh; Karen Ruth; Walter J Scott; Barbara A Burtness; Steven J Cohen; Andre A Konski; Harry S Cooper; Igor Astsaturov; Joshua E Meyer
Journal:  Ann Thorac Surg       Date:  2014-11-18       Impact factor: 4.330

8.  Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer.

Authors:  Kelly R Haisley; Amy E Laird; Nima Nabavizadeh; Ken M Gatter; John M Holland; Gina M Vaccaro; Charles R Thomas; Paul H Schipper; John G Hunter; James P Dolan
Journal:  JAMA Surg       Date:  2016-11-16       Impact factor: 14.766

9.  Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.

Authors:  Emmanuel Gabriel; Kristopher Attwood; William Du; Rebecca Tuttle; Raed M Alnaji; Steven Nurkin; Usha Malhotra; Steven N Hochwald; Moshim Kukar
Journal:  JAMA Surg       Date:  2016-03       Impact factor: 14.766

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245
View more
  1 in total

1.  Esophageal resection after neoadjuvant therapy: understanding the limitations of large database analyses.

Authors:  David N Ranney; Michael S Mulvihill; Babatunde A Yerokun; Matthew G Hartwig
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.